Aim: Coronary collateral vessels are an alternative source of blood supply to a myocardial area jeopardized by ischemia. As some patients have poor collaterals despite significant stenosis, it is thought that multiple factors affect collateral development beside coronary artery disease severity. Mean platelet volume is an indicator of platelet activation. Increased mean platelet volume is found to be related to worse prognosis in the coronary artery disease. In this study, we aimed to investigate the relationship between mean platelet volume and coronary collateral development. Material and Method: Patients with total occlusion in at least one coronary artery were enrolled in this study. Coronary angiography images of 367 patients without a history of revascularization were evaluated retrospectively, and coronary collateral development was graded according to Rentrop classification. Patients were divided into two groups based on Rentrop classification. Rentrop grade 0-1 was regarded as poor collateral development, and Rentrop 2-3 was regarded asgood collateral development. Mean platelet volume was compared between these two groups. Results: Poor collateral development was found in 236 patients (64.3%), and good collateral development was found in 131 patients (35.7%). There was no statistically significant difference in mean platelet volume levels between two groups (9.9±1,2 fL and 10.3±1.3 fL p=0,228). The 3-vessel disease was found to be a predictor of good collateral development (p=0.024). Discussion: In this study, it was found that there was no relationship between mean platelet volume and coronary collateral development.
Introduction
Platelets play an important role in the pathogenesis of coronary artery disease (CAD). Their reactivity is a key issue and platelet size, simply measured by mean platelet volume (MPV), is an indirect marker of platelet reactivity [1, 2] . Large platelets have a greater content of granules, higher thrombotic potential, increased thromboxane synthesis and serotonin release [3] [4] [5] . It has been reported that elevated MPV is associated with increased mortality following myocardial infarction and increased cardiovascular events in patients undergoing either an elective or urgent percutaneous coronary intervention [2, 6] . Coronary collateral vessels serve as an alternative source of blood supply to an ischemic myocardium. Poor collateral development was found to be associated with larger infarct size and mortality in CAD patients [7, 8] . One of the well-established determinants of collateral formation is coronary artery stenosis, but poor collateral development despite significant stenosis suggest that multiple mechanisms contribute to collateral formation [9] . Some mediators such as nitric oxide (NO), vascular endothelial growth factor, thromboxane, prostacyclin take part in the formation of collateral vessels [10] [11] [12] . In this study, we aimed to evaluate the relationship between MPV and coronary collateral formation in CAD patients.
Material and Method
The present study is a retrospective cross-sectional study. Between July 2011 and August 2012, 367 patients who underwent coronary angiography at our institution were enrolled in this study. All patients underwent coronary angiography because of suspicion of CAD based on their symptoms or diagnostic tests. Patients with at least one totally occluded major epicardial coronary artery were included in the study. Demographic and clinical data including age, gender, the prevalence of DM, hypertension, dyslipidemia, smoking history, and clinical presentation were obtained from all patients. Exclusion criteria were as follows: previous coronary revascularization history, history of malignancy or inflammatory disease, evidence of infectious disease, severe hepatic, or renal insufficiency, receiving anticoagulants and having congenital or acquired blood disorders. Also, patients with incomplete data were excluded. The study was approved by the local ethics committee. Venous peripheral blood samples for complete blood count were drawn from patients undergoing elective (following a fasting period of 12 hours) or urgent coronary angiography (on admission). Blood samples were taken into standardized, EDTA containing tubes. Platelet parameters including count and MPV were determined by Beckman Coulter LH 780 Hematology Analyzer. Measurements were completed within one hour of blood sampling to avoid the EDTA induced platelet swelling with time. Angiographic Procedure and Coronary Collateral Grading Coronary angiography was performed via the femoral artery for all patients using the Judkins technique. Coronary stenosis degree, infarct related artery (IRA), and coronary collateral grading were estimated by two independent cardiologists who were blinded to the clinical information and laboratory parameters of the patients. Patients with at least one coronary artery with a total occlusion were enrolled in the study. Coronary collateral development was graded according to Rentrop classification: 0= no filling of any collateral vessel; 1= filling of the side branches of the the artery to be perfused by collateral vessels without visualization of the epicardial segment; 2= partial filling of the distal epicardial segment by collateral vessels; 3= complete filling of the distal epicardial segment by collateral vessels. Rentrop 0-1 was graded as poor collateral development, and Rentrop 2-3 was graded as good collateral development [13] .
Statistical analysis
The Kolmogorov-Smirnov test was used to evaluate normal distribution. Continuous variables were expressed as mean ± standard deviation (SD), and categorical variables were defined as numbers and percentages. Student's t-test or oneway analysis of variance (ANOVA) was used to compare continuous variables. Differences in the distribution of categorical variables were assessed using chi-square analysis. The best predictors of the poor collateral development were evaluated by multiple logistic regression analysis. Any variable whose univariable test had a p value <0.25 was accepted as a candidate for the multivariable model along with all variables of known clinical importance. Adjusted odds ratios and 95% confidence intervals (CIs) were also calculated. The results were considered significant when the p value was <0.05.
Results
The mean age of the study population was 61.6±12.4, and 74% of the patients were male. 94 patients had a diagnosis of stable angina pectoris, 97 patients had unstable angina pectoris or non-ST elevation myocardial infarction, 176 had ST elevation myocardial infarction. Of the 367 patients, 131 patients (35.7 %) had good collateral development, and 236 patients (64.3 %) had poor collateral development. The two groups did not differ for age, gender, diabetes mellitus, hyperlipidemia, hypertension, and smoking history. The demographic and laboratory characteristics of the groups are shown in Table 1 . Mean MPV was 10.0±1.3 fL, and the mean platelet count was 248.2±64 (1000/μL). The mean MPV was 10.3±1.3 fL in the good collateral group and 9.9±1.2 fL in the poor collateral group. There was no difference regarding mean MPV between two groups (p=0.228). Platelet count was not different between two groups (p=0.083). White blood cell count was higher in the poor collateral group than good collateral group (p=0.021). There were more patients with 3-vessel disease among the patients with good collateral development compared to patients with poor collateral development (p=0.016). In multivariate analysis, three vessel disease was found to be a predictor of good collateral development (odds ratio 0.595, 95%CI: 0.380-0.933, p=0.024).
Discussion
In our study, we investigated whether MPV is related to collateral development in patients with CAD. We found that the MPV levels were not related to coronary collateral development. A well developed coronary collateral limits the ischemia, reduce the size of myocardial infarction, preserve left ventricle function, and has a favorable impact on the prognosis of patients with coronary artery disease [8, 14] . Collateral vessels are a valuable source for alternative blood supply to ischemic myocardium especially in case of unachievable revascularization. But, there is notable variation in the degree of coronary collateral development. Collateral development is a multifactorial process, and it is important to define the factors that facilitate collateral development. Platelets play a crucial role in the pathogenesis of atherosclerotic complications, and they are important targets for the treatment of coronary artery disease. MPV is an indirect marker of platelet activity. Larger, metabolically, and enzymatically more active platelets have greater prothrombotic features [5] . Elevated MPV was associated with worse clinical outcomes in patients with CAD [2] . Whether platelets with elevated MPV affect outcomes for worse by collateral formation or not hasn't been explained clearly. Previous studies about this issue are controversial. In a study of patients with the acute coronary syndrome, high MPV on admission was found to be associated with the presence of coronary collateral formation [15] . In contrast, in another study, elevated MPV was found to be a predictor of inadequate collateral development [16] . Some studies revealed that MPV levels were not related to coronary collateral development [17] [18] [19] . We also found that there wasn't any significant relation between the collateral formation and MPV. Our study differed from the studies mentioned above in some aspects. Patients with >%50, >%80 or >%90 stenosis were enrolled in some of the previous studies. As the variations of the severity of the stenosis may affect collateral formation, we enrolled patients with at least one totally occluded major coronary artery. Also, there is a difference in classification of patients according to Rentrop classification. Rentrop 2-3 collaterals were accepted as good collateral formation in our study, whereas only Rentrop 3 was accepted as adequate collateral development in some studies. In a study by Tan et al. platelet activation was measured by soluble CD40 ligand, soluble P-selectin, and soluble glycoprotein V. They reported that the correlation between the degree of collateralization and these platelets activation markers was not significant [20] . Thromboxane A2 and serotonin have been shown to cause vasoconstriction of the collateral vessels [21] . Large platelets have a greater content of granules, increased thromboxane synthesis and serotonin release. It is possible that activated platelets within collateral vessels could cause vasoconstriction and decrease collateral flow. It has been reported that platelet activating factor caused a decrease in coronary collateral flow with the participation of thromboxane A2 [12] . It has been reported that serotonin blocker augments flow reserve of the collateral circulation in anginal patients [22] . Collateral development is a multifactorial process, and the further studies are required to understand the role of activated platelets in collateral formation.
Conclusion
In conclusion, MPV levels were not related to coronary collateral development in a group of patients with either stable coronary artery disease or acute coronary syndrome. Our study has some limitations. First, it is a retrospective study. 
